Stock GEAN GENETIC ANALYSIS
Add to a list
To use this feature you must be a member
Log inSign up

Company Genetic Analysis

Equities

GEAN

NO0010692130

Healthcare Facilities & Services

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
0.67 NOK +9.84% Intraday chart for Genetic Analysis +23.62% -21.18%
Feb. 29 Genetic Analysis AS Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Feb. 26 Genetic Analysis AS Announces CE-IVD Marking for its GA-map Sample Collection Kit CI

Business Summary

Genetic Analysis AS is a Norway-based company active in the field of molecular diagnostics of diseases related to large and small intestine (gut) imbalances. The Company has developed a DNA-based platform technology that allows for simultaneous analysis of a number of similar (but not identical) gene fragments in one reaction. The GA-map platform technology utilizes common and variable DNA sequences within the 16S rRNA gene of the bacteria to characterize and identify the different bacteria. The technology makes it possible to generate profiles of a person's microbiota and correlate that profile to different health conditions.

Number of employees: 21

Sales per Business

NOK in Million2022Weight2023Weight Delta
Diagnostics Test Products
68.0 %
9 79.6 % 10 68.0 % +8.19%
Diagnostics Test Services
21.3 %
1 8.8 % 3 21.3 % +206.96%
Platform Installation
10.7 %
1 11.6 % 2 10.7 % +17.17%

Sales per region

NOK in Million2022Weight2023Weight Delta
United States
51.8 %
8 67.2 % 7 51.8 % -2.37%
Europe
33.4 %
2 21.2 % 5 33.4 % +99.16%
Rest of World
14.9 %
1 11.6 % 2 14.9 % +62.79%

Managers

Managers TitleAgeSince
Ronny Hermansen CEO
 Chief Executive Officer 62 14-03-31
Eilert Aamodt DFI
 Director of Finance/CFO 54 20-12-31
Lars Tiller COO
 Chief Operating Officer - 22-03-03
Kari Furu CTO
 Chief Tech/Sci/R&D Officer 44 15-12-31
Christina Casèn CTO
 Chief Tech/Sci/R&D Officer 64 08-12-31

Members of the board

Members of the board TitleAgeSince
Rune Sørum BRD
 Director/Board Member 68 09-12-31
Camilla Huse Bondesson BRD
 Director/Board Member 66 19-12-31
Per Matsson CHM
 Chairman 70 -
Andrew Stapleton BRD
 Director/Board Member 68 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 38,199,319 17,011,475 ( 44.53 %) 0 44.53 %

Company contact information

Genetic Analysis AS

Ulvenveien 80

0581, Oslo

+47 48 32 16 10

http://www.genetic-analysis.com
address Genetic Analysis(GEAN)

Sector

Healthcare
Healthcare Services
Healthcare Providers & Services
Healthcare Facilities & Services
Medical & Diagnostic Laboratories

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
GENETIC ANALYSIS Stock Genetic Analysis
-21.18% 2.57M
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-17.58% 8.36B
RADNET, INC. Stock RadNet, Inc.
+40.49% 3.6B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-32.64% 2.73B
SYNLAB AG Stock SYNLAB AG
-8.06% 2.47B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-7.67% 2.32B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-14.40% 1.77B
FLEURY S.A. Stock Fleury S.A.
-18.74% 1.55B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-40.19% 1.22B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+5.57% 1.09B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. GEAN Stock
  4. Company Genetic Analysis